The relatedness of swine vesicular disease virus (SVDV) and Coxsackie B5 virus has been studied by virus neutralization and immunodiffusion tests and by hybridization of the virus RNAs. Clearly defined differences between the two viruses were found by the three methods. Isolates of SVDV from several countries were very closely related but could be differentiated. Recent isolates of Coxsackie B5 virus also appeared to be similar but clear differences could be detected between these and the prototype (Faulkner) strain of the virus. The SVDV isolates were more closely related to the Faulkner strain than to the recent isolates of Coxsackie B5 virus. Perhaps of more importance, the Faulkner strain was more closely related to SVDV than it was to the recent Coxsackie B5 isolates. The significance of these observations in relation to the recent emergence of swine vesicular disease is discussed.
INTRODUCTION
Swine vesicular disease was first observed in Italy in 1966 (Nardelli et al. 1968 ) and physicochemical examination indicated that the causative agent was an enterovirus. Subsequent outbreaks occurred in Hong Kong in 197I (Mowat, Darbyshire & Huntley, I972) and in Europe and Japan in x972-5 (Brooksby, I975). The important observation that SVDV was neutralized by Coxsackie B5 virus antiserum (Graves, I973) raised questions regarding the origin of the swine virus.
In preliminary experiments Brown, Talbot & Burrows 0973) showed that, despite the close relationship between the two viruses, they could be distinguished by immunodiffusion tests. The results described in this paper show that the two viruses can also be differentiated by neutralization tests. Homology tests with the virus RNAs, which are also described, support the serological data and give another measure of the relatedness of the two viruses. The data indicate that it may be possible to elucidate the origin of the swine virus.
METHODS
Viruses. The following viruses were grown at 37 °C in monolayers of IBRS-2 cells (de Castro, 1964 ) in Eagle's medium: (a) SVDV (United Kingdom, UK 27[72; Hong Kong, HK 71 ; Italy 66 and Italy 73); (b) Coxsackie B 5 virus (Faulkner prototype strain; isolates 8068 and 9954 from patients in the Birmingham area in 1973); (c) Talfan virus. The SVD and Coxsackie B5 viruses had been passaged only twice in IBRS-2 cells and were not cloned so that they retained as far as possible the characteristics of the original isolates.
Purification of virus particles'. Two methods were used. In the first, the virus pellets obtained by centrifuging the harvests at 6oooog for 2 h were suspended in o'o4 M-phosphate, insoluble debris removed at 2ooo g and the clarified suspensions mixed with I ~ SDS and centrifuged for 2"5 h at 6oooog in a I5 to 45 ~ sucrose gradient in o'o4 M-phosphate or o.I M-tris, pH 7"6 using the SWz5.t rotor of the Spinco Ultracentrifuge. In the second method, the dispersed pellet was mixed with I ~ Nonidet P4o and centrifuged to equilibrium at 8oooog in a pre-formed caesium chloride gradient (p = I"3o to I"4o g/ml). In each method fractions were collected from the bottom of the tube and the densities of the fractions from the caesium chloride gradients were estimated from refractive index measurements. As an aid to the location of the virus particles in the sucrose and caesium chloride gradients, trace amounts of 3H-uridine or zSS-methionine were incorporated into the viruses during replication and the distribution of radioactivity in the fractions measured.
Preparation ofantisera. (a) Guinea pig antisera were obtained by inoculating the animals subcutaneously with a mixture of sucrose gradient purified virus and aluminium hydroxide gel. A second inoculation of virus, without adjuvant, was made three weeks later and the animals were killed and exsanguinated after a further three weeks. (b) Convalescent pig serum was obtained from animals infected with SVDV between 2I and 28 days after infection.
Neutralization tests. Two methods were used. In the first, mixtures of equal volumes (25 #1) of Io-fold dilutions of virus and I/lO0 or I]5oo antiserum in Eagle's medium containing Io ~ tryptose phosphate broth were prepared in micro-titre plates, incubated at 37 °C for I h and 25 #1 of a suspension of IBRS-2 cells containing 106 cells per ml of Eagle's medium supplemented with IO ~ serum and Io ~ tryptose phosphate broth were then added. Eight wells were used for each io-fold dilution of virus. After 3 days at 37 °C in an atmosphere containing 5 ~ CO2, the plates were fixed for 3o rain with Io ~ formalin in phosphate buffered saline and then stained with o.i ~ methylene blue. In the wells in which the virus had been neutralized, a stained monolayer of cells was clearly seen. In those wells which contained virus which had not been neutralized, the cells lysed and prevented the formation of a cell sheet. The titres were calculated by the method of Karber (I93 I). In the second method, the mixtures of Io-fold dilutions of virus and I/Ioo antiserum were incubated at 37 °C for I h and then assayed for plaque forming units on monolayers of IBRS-2 cells. In each method, the neutralizing activity of the serum dilution was taken as the difference between the titre of the virus alone and that of the virus-serum mixture.
hnmunodiffusion tests. Ouchterlony's method (I948) was used, substituting agarose for agar. A concentration ofo.85 ~ agarose in o'15 M-NaC1 containing o'I ~ sodium azide was used. Purified preparations of full and empty particles from caesium chloride gradients were allowed to diffuse towards hyperimmune guinea pig serum and the plates were recorded daily for seven days.
Preparation of virus RNA. Sucrose gradient purified virus was diluted with o.I M-tris buffer, pH 7"6, and extracted with phenol in the presence of 0.2 ~ SDS. The aqueous layer was shaken with ether to remove phenol and the RNA then precipitated with 2 vol. ethanol at -2o °C.
Preparation of 3H-uridine labelled double-stranded RNA. Monolayers of IBRS-2 or HeLa
cells were infected at a multiplicity of Io to 50 and then incubated at 37 °C in Eagle's medium containing 8H-uridine (io #Ci/ml) and actinomycin D (I #g/ml). After 6 to 8 h the cells were extracted with phenol and the aqueous layer precipitated with 2 vol. ethanol at -2o °C. The precipitate was dissolved in STE buffer (o"I5 M-NaC1, o.m M-tris, O'OOI M-EDTA, pH 7"6) and made to 2 M-NaC1 to precipitate single-stranded RNA. After I8 h at 4 °C, the precipitate UK 27/72 guinea pigt 3"o 2.6 3'0 1.9 2"5 UK 27/72 swine 4'3 4"5 3"8 2'6 2' 9 HK 71 guinea pigi 4"o 4"2 4"3 3 .0 3"5 HK 7I swine 1"9 2,6 2"3 o'9 0"9 Faulkner guinea pig 2.6 3"1 ~ 5"9 l "5 I "5 8o68 guinea pig o.8 o'7 1.3 3"9 3"9 9954 guinea pig 2"5 2.8 2"5 ~4"4 ~4"6 * The tests were made in micro-titre plates using virus dilutions and constant serum dilution. The values in the table represent means of at least three separate assays. Variation between tests was less than 0"5 log.
? The marked guinea pig sera were used at a dilution of 1, all other guinea pig and swine sera were used at a dilution of T0~ -.
was removed by centrifuging at 4000 g and the supernatant fluid precipitated with 2 vol. ethanol at -20 °C. This latter precipitate, which contained the double-stranded RNA, was dissolved in o.I M-NaCI-o.I ~ SDS and centrifuged in a 5 to z 5 ~ sucrose gradient in the same solution. The peak of RNA sedimenting at about 2oS was used for the hybridization experiments.
Hybridization. The technique was similar to that described by Baltimore 0966). A mixture of 6 to 9/zg of unlabelled virus RNA and ~H-double-stranded RNA in a total vol. of Ioo/zl was denatured with o.I ml of o.2 z<-NaOH for 9o s and then neutralized with o'3 ml of o. 5 M-tris, pH 7"6; o.I ml of Io × SSC (I"5 M-NaC1, o'I5 M-Na citrate) was then added and the mixture heated to Ioo °C for 3 min followed by 6o °C for 2 h. Unhybridized RNA was removed by incubation with pancreatic ribonuclease (5o/~g/ml) and T~ ribonuclease (5o units]ml) for I5 min at 37 °C and the undigested 3H-RNA was then estimated by precipitating with Io ~ TCA and collecting on Millipore filters. In the calculation of the cross-hybridization between different viruses, the hybridization in the homologous reaction was taken as IOO ~.
RESULTS

Neutralization tests
The results of the neutralization tests with guinea pig antisera in the micro-titre plates, which are summarized in Table I , allow the following conclusions to be made: (~) the two SVDV isolates cannot be distinguished by this test; (2) the recent isolates (8o68 and 9954) of Coxsackie B5 virus are indistinguishable but each differs considerably from the Faulkner prototype strain; (3) the Faulkner strain antiserum neutralizes the two SVDV isolates rather better than it neutralizes the recent Coxsackie B 5 isolates; (4) the SVDV antisera neutralize the Faulkner strain to a greater extent than they neutralize the recent Coxsackie B 5 isolates. Similar results were obtained with the convalescent pig sera from animals infected with SVDV and the hyperimmune guinea pig sera prepared against the same viruses (Table I) . The extent of neutralization by any of the sera was considerably lower when measured by the plaque reduction method, but the results were qualitatively similar. 
Immunodiffusion tests
In tests with homologous antiserum the full and empty particles of each of the five viruses formed spur lines indicating a reaction of partial identity. Consequently for the comparison of the different isolates, separated full particles were used. To obtain the concentration of particles necessary for the formation of distinct precipitin lines, the full particles were prepared by centrifuging Nonidet treated virus pellets to equilibrium in caesium chloride gradients (see Methods).
In the tests with these purified particles, a line of identity was observed with all the viruses and antisera. In addition, however, a distinct spur line was obtained between each of the SVDV preparations and each of the Coxsackie B5 viruses (Fig. I) . Spur lines were also obtained with the Faulkner strain and the two recent Coxsackie B5 isolates; the intensity of these spur lines was usually as great as that obtained with the SVDV and Coxsackie B5 isolates. It was also noticed that the line common to both viruses in a reaction involving a Coxsackie B5 and an SVDV isolate was usually more intense between a virus and its homologous serum (see for example Fig. I d) .
The 8o68 and 9954 isolates appeared to be identical. The two SVDV isolates seem to be very closely related (Fig. I a and b) although faint spur lines were usually observed, suggesting a slight antigenic difference between the two isolates (Brown et al. I973) .
R N A homology tests
Brown & Wild (~974) demonstrated that there is about 50 ~ homology between the R N A of the U K 27]72 isolate of SVDV and RNAs of both the prototype (Faulkner) strain and the recent Coxsackie B5 isolates (8o68 and 9954). These tests have been extended to include comparisons between additional isolates of SVDV and double-stranded R N A from SVDV * The results are expressed as the percentage of radioactivity annealing with the heterologous virus RNA compared with the homologous virus RNA. The tests were made with excess unlabelled virus RNA and about lOOO ct/min of double-stranded 3H-RNA were used in each assay. Self-annealing, which was about 3 to 5 ~, was subtracted from the values obtained for the homologous and heterologous hybridization reactions. 47 to 52 ~ of the radioactivity in the double-stranded RNA was hybridized by the homologous virus RNA.
t ND, not determined. Table 2. and Coxsackie B5 virus infected cells. (Tables 2 and 3 ). For ease of comparison, some of the data from the paper by Brown & Wild (I974) are included in Table 3 . The RNAs of four isolates of SVDV showed a high degree of homology but small differences were apparent (Table 2) . For example the RNA of the UK 27/72 virus isolated in I972 and that of the HK 7I virus isolated in I97I differed slightly from each other and from the RNA of the virus isolated in Italy in I966. The RNA from a virus isolated in Italy in ~973, however, was completely homologous with that of the UK 27/72 virus RNA. These observations correlate with the immunodiffusion tests reported previously (Brown et al. ~973 )-Unfortunately it was not possible to measure the degree of homology with the doublestranded RNA from HK 7I virus infected cells because of difficulties in isolating this RNA with sufficient radioactivity.
The data in Table 3 show that the RNA of SVDV (UK 27/72 ) is as closely related to the Coxsackie B5 virus RNAs as the individual Coxsackie B5 virus RNAs are related to each other. A few experiments with other isolates of SVDV have given similar results.
Although the method used for these experiments has obvious drawbacks, particularly with regard to the integrity of the RNA molecules after the brief treatment with NaOH, it has advantages when applied to the comparison of several different RNAs. Competition hybridization experiments with unlabelled double-stranded RNA and labelled virus RNA should yield more precise data on the relationships between the different RNAs.
DISCUSSION
Despite the close relationship between SVDV and Coxsackie B5 virus, our results show that the viruses can be distinguished. The neutralization and immunodiffusion data demonstrate, in addition, that the recent Coxsackie B5 isolates differ markedly from the prototype strain of the virus isolated in I952 , thus confirming the RNA annealing studies of Brown & Wild (~974) . The immunodiffusion tests also show that isolates of SVDV can be differentiated. This is confirmed by the RNA hybridization results (Tables 2 and 3 ) and agrees with the results obtained by analysis of virus particle polypeptides on polyacrylamide gels (Harris & Brown, I975) . It emerges also from the neutralization tests that the SVDV isolates are rather more closely related to the prototype strain of Coxsackie B5 virus than to the recent isolates.
In view of these relationships it is interesting to speculate on the origin of SVDV. Swine vesicular disease was not reported until I966 and its close clinical similarity to the internationally controlled foot-and-mouth disease makes it unlikely that an outbreak of the swine disease would have been overlooked. On the other hand Coxsackie B5 virus was first identified in I952 and it seems possible that a variant of this virus could be the causative agent of swine vesicular disease. There was no abnormal incidence of illness due to Coxsackie B5 virus infections in the Midlands area, where the first outbreak of swine vesicular disease in England occurred in December I972 , and the clearly defined serological difference between the recent Coxsackie B5 virus isolates and the SVDV isolates would make it unlikely that the swine disease had been caused by a prevailing Coxsackie B5 virus. It would seem more likely, from the closer antigenic relationship of SVDV with the prototype strain of Coxsackie B5 virus, that if the virus which infected swine is a Coxsackie B5 virus, it is more likely to have descended from the prototype strain than from a recent strain. However, attempts to infect swine with the Faulkner prototype strain were unsuccessful (Graves, I973; Garland & Mann, I974; W. Uhlmann, personal communication) but this may have been because the virus used in these experiments had been passaged several times in 'unnatural" hosts before inoculation into swine. It is also possible that avirulent strains of SVDV were circulating among swine and have emerged in a more virulent form to cause clinical disease.
The difference between the prototype Coxsackie B5 virus and more recent isolates, as measured by the RNA homology tests (Brown & Wild, I974) , is as great as that found between different serotypes of poliovirus (Young, ~973) and foot-and-mouth disease virus (Dietzschold et al. I97I). The neutralization tests also demonstrate the large antigenic variation which has occurred in the Coxsackie B5 viruses during the 21 years between their isolation. By examining strains of Coxsackie B5 virus isolated between I952 and I973 it might be possible to elucidate the origin of the swine virus.
